Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York.
Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York
J Pharmacol Exp Ther. 2021 Feb;376(2):261-272. doi: 10.1124/jpet.120.000385. Epub 2020 Dec 4.
A semimechanistic physiologically based pharmacokinetic (PBPK) model for chloroquine (CQ), a highly lysosomotropic weak base, was applied to digitized rat and human concentration versus time data. The PBPK model in rat featured plasma and red blood cell (RBC) concentrations, extensive and apparent nonlinear tissue distribution, fitted hepatic and renal intrinsic clearances, and a plasma half-life of about 1 day. Tissue-to-plasma CQ ratios at 50 hours after dosing were highest in lung, kidney, liver, and spleen (182-318) and lower in heart, muscle, brain, eye, and skin (11-66). The RBC-to-plasma ratio of 11.6 was assumed to reflect cell lipid partitioning. A lysosome-based extended model was used to calculate subcellular CQ concentrations based on tissue mass balances, fitted plasma, interstitial and free cytosol concentrations, and literature-based pH and pKa values. The CQ tissue component concentrations ranked as follows: lysosome > > acidic phospholipid > plasma = interstitial = cytosol ≥ neutral lipids. The extensive lysosome sequestration appeared to change over time and was attributed to lowering pH values caused by proton pump influx of hydrogen ions. The human-to-rat volume of distribution () ratio of 7 used to scale rat tissue partitioning to human along with estimation of hepatic clearance allowed excellent fitting of oral-dose PK (150-600 mg) of CQ with a 50-day half-life in humans. The prolonged PK of chloroquine was well characterized for rat and human with this PBPK model. The calculated intratissue concentrations and lysosomal effects have therapeutic relevance for CQ and other cationic drugs. SIGNIFICANCE STATEMENT: Sequestration in lysosomes is a major factor controlling the pharmacokinetics and pharmacology of chloroquine and other cationic drugs. This report provides comprehensive physiologic modeling of chloroquine distribution in tissues and overall disposition in rat and human that reveals expected complexities and inferences related to its subcellular association with various tissue components.
一种半机械的、基于生理学的氯喹(CQ)药代动力学(PBPK)模型,被应用于数字化的大鼠和人体的浓度-时间数据。大鼠的 PBPK 模型具有血浆和红细胞(RBC)浓度、广泛且明显的非线性组织分布、拟合的肝和肾内在清除率,以及约 1 天的血浆半衰期。给药后 50 小时,组织与血浆 CQ 比值在肺、肾、肝和脾中最高(182-318),在心、肌肉、脑、眼和皮肤中较低(11-66)。红细胞与血浆比值为 11.6,被认为反映了细胞内的脂质分配。基于溶酶体的扩展模型用于根据组织质量平衡计算亚细胞 CQ 浓度,拟合血浆、间质和游离细胞溶质浓度,以及基于文献的 pH 值和 pKa 值。CQ 组织成分浓度的排序如下:溶酶体>酸性磷脂>血浆=间质=细胞溶质≥中性脂质。广泛的溶酶体隔离似乎随时间而变化,这归因于质子泵流入氢离子导致 pH 值降低。用于将大鼠组织分配比例缩放至人体的人-鼠体积分布(Vd)比值为 7,以及肝清除率的估算,使口服 CQ(150-600mg)的 PK(50 天半衰期)在人体中得到极好的拟合。该 PBPK 模型很好地描述了 CQ 在大鼠和人体中的 PK 特征。计算的组织内浓度和溶酶体效应与 CQ 和其他阳离子药物的治疗相关。意义:溶酶体的隔离是控制氯喹和其他阳离子药物的药代动力学和药理学的主要因素。本报告提供了氯喹在组织中的分布以及在大鼠和人体中的整体处置的全面生理建模,揭示了与其与各种组织成分的亚细胞结合相关的预期复杂性和推断。